Navigation Links
Acumen in Medical News
REDWOOD CITY, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Genelabs
Technologies, Inc. (Nasdaq: GNLB ) announced today that the company will be
webcasting its corporate presentation at the Acumen BioFin Rodman & Renshaw
9th Annual Healthcare Conference on Wednesday, November 7th at 8:50 am
Easter...
CRANBURY, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (Amex: PTN ) today announced that it will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at the New York Palace Hotel in New York on Monday, November 5, 2007 at 4:45 PM ET. Carl Spana,...
NEW YORK, Nov. 1 /PRNewswire/ -- NexGenix Pharmaceuticals, a privately held biotechnology company focused on developing drugs to treat the orphan- designated tumor suppressor disorder neurofibromatosis and related sporadic tumors, today announced that Allan E. Rubenstein, MD, Chief Executive O...
NEW YORK, Oct. 31 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. (Amex: MGT ), a holding company focused on the Healthcare Information Technology sector, announced today that it plans to present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at the New York Pa...
HAE: TSX MONTREAL, Oct. 31 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a specialty bio-therapeutics company, announces the webcast of its presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference, on November 7, 2007 at 11...
WELLESLEY, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Coley Pharmaceutical Group, Inc. (Nasdaq: COLY ), today announced that Robert L. Bratzler, Ph.D., Coley's President and Chief Executive Officer, plans to provide a corporate update at the upcoming the Acumen BioFin Rodman & Renshaw 9th Annua...
CRANBURY, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (Amex: PTN ) today announced that it will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at the New York Palace Hotel in New York on Monday, November 5, 2007 at 4:45 PM ET. Carl Spana,...
NEW YORK, Nov. 1 /PRNewswire/ -- NexGenix Pharmaceuticals, a privately held biotechnology company focused on developing drugs to treat the orphan- designated tumor suppressor disorder neurofibromatosis and related sporadic tumors, today announced that Allan E. Rubenstein, MD, Chief Executive O...
Dynavax to Present at CIBC World Markets and Acumen BioFin Rodman and Renshaw Healthcare Conferences
BERKELEY, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX ) announced today Michael S. Ostrach, Vice President and Chief Business Officer, will present an overview of the company at two investor conferences in New York City the first week of November. O...NEW YORK, Oct. 31 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. (Amex: MGT ), a holding company focused on the Healthcare Information Technology sector, announced today that it plans to present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at the New York Pa...
HAE: TSX MONTREAL, Oct. 31 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a specialty bio-therapeutics company, announces the webcast of its presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference, on November 7, 2007 at 11...
WELLESLEY, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Coley Pharmaceutical Group, Inc. (Nasdaq: COLY ), today announced that Robert L. Bratzler, Ph.D., Coley's President and Chief Executive Officer, plans to provide a corporate update at the upcoming the Acumen BioFin Rodman & Renshaw 9th Annua...
Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
- Live Webcast on Tuesday, November 6 at 8:50 a.m. ET - TROY, Mich., Oct. 31 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS ) announced that William Iacona, Somanetics' chief financial officer, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Co...BioMS Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
EDMONTON, Oct. 31 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the Acumen BioFin Rodman and Renshaw 9th Annual Healthcare Conference in New York. ...Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
WESTMINSTER, Colo., Oct. 31 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that Paul L. Berns, President and CEO, will ...Acumen in Medical Technology
Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Amex: IMM ) announced today that it will present at the Acumen BioFin(TM) Rodman & Renshaw 9th Annual Healthcare Conference. On Tuesday, November 6 at 2:40 p.m. Eastern Time, Immtech is scheduled to present in the Hubb...Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
GAITHERSBURG, Md., Nov. 2 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI ) today announced that Stanley C. Erck, the company's president and chief executive officer, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference in New York City on Monday, Nov....ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
EXTON, Pa., Oct. 31 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that Michel de Rosen, president and chief executive officer of ViroPharma, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at 8:50 A.M. ET on Tuesday, Nove...Acumen in Medical Products
Acumen™ Surgical Navigation System
Description:... During fiscal year 2004, Biomet plans to introduce the acumen Surgical Navigation System to the global market, enhancing visualization for minimally-invasive and traditional procedures. The acumen technology was developed in conjunction with Z-KAT, Inc., a private company...Company:Biomet Orthopedics, Inc
Acumen in Biological News
CCNY receives $5 million NSF grant to establish center for nanostructure applications
...pportunities between sensor and energy systems application since they can draw upon a "common pool of nanomaterial systems. Also, much of the research acumen will be derived from scientists engaged in projects in both areas," he added. The grant will fund projects that potentially involve 21 professors a...Chemist Brings SAFETY Act Expertise to Homeland Security Firm
...gies with homeland security uses," said David Olive, a principal and co-founder of the firm. "His unique combination of scientific expertise, business acumen and political know-how is vital to companies navigating this often complicated process." Dr. McWhorter was personally recognized by Adm. Jay M. Cohe...Acumen in Biological Technology
- Presentation to be Webcast -
MONTVALE, N.J., May 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics,
Inc. (Amex: SYI ) announced today that Noah Berkowitz, M.D., Ph.D. President
and Chief Executive Officer of Synvista will present at the upcoming Rodman
& Renshaw 5th An...
CALGARY, Nov. 1 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007 at 3:20 p.m. E...
FREMONT, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML ) announced today that it will webcast its presentation at the Acumen BioFin 9th Annual Healthcare Conference in New York. Gail Page, President & CEO, will provide a company overview at 3:45 p.m. Eastern on Tues...
SAN MATEO, Calif., Oct. 31 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing novel pain management therapies, announced today that it is scheduled to present on Monday, November 5, 2007 at the CIBC World Markets 18th Annual Healthcare...
BETHESDA, Md., Oct. 31 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammation and autoimmune diseases, today announced that Dr. Christian Itin, President and Chief...
SyntheMed to Present at the Acumen BioFin Conference
ISELIN, N.J., Nov. 2 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products, announced today that Robert P. Hickey, President and CEO, will present at the ACUMEN B...CALGARY, Nov. 1 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007 at 3:20 p.m. E...
FREMONT, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML ) announced today that it will webcast its presentation at the Acumen BioFin 9th Annual Healthcare Conference in New York. Gail Page, President & CEO, will provide a company overview at 3:45 p.m. Eastern on Tues...
Nastech to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
BOTHELL, Wash., Oct. 31 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK ) announced today that it will present at the Acumen BioFin Rodman & Renshaw Healthcare Conference on Monday, November 5, 2007 at 2:40 p.m. Eastern Time at the New York Palace Hotel in New York...Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference
LONDON, October 31 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN ) ("Amarin" or the "Company") today announced that Rick Stewart, Chief Executive Officer of Amarin, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6 at 1...SAN MATEO, Calif., Oct. 31 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing novel pain management therapies, announced today that it is scheduled to present on Monday, November 5, 2007 at the CIBC World Markets 18th Annual Healthcare...
MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Company Provides Revised Timing on Interim Celgosivir Viral Kinetics Study Data VANCOUVER and SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases will present at the Acumen ...BETHESDA, Md., Oct. 31 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammation and autoimmune diseases, today announced that Dr. Christian Itin, President and Chief...
Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
VIENNA, Va., Oct. 31 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today announced that senior management will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Wednesday, November 7, 2007 at 1:40 pm ET. The conference will be held at the Ne...Other TagsOther Contents
(Date:6/18/2013)... Exposed Skin Care has finally been released after ... all ages finally achieve the clear, beautiful skin they have ... acne clearing system combines the power of science and nature ... forming. , After a quick review of ... of the most effective available on the market to cure ...
(Date:6/18/2013)... An apple a day might really keep the ... breast cancer, she chose a different method for beating ... Cancer, I Can Take It Away!: Alternatives Brought Me ... how changing her physical, mental and emotional diet cured ... to feel fearful when diagnosed with a disease of ...
(Date:6/18/2013)... As obesity rates sky rocket in the ... equipment during childbirth comes as no shock. Forceps are surgical ... when she is unable to do so herself and although ... higher rates of complication for both the mother and the ... mother and child, forceps births add to the pressure of ...
(Date:6/18/2013)... 2013 Parker Waichman LLP , ... of victims injured by defective medical devices, reports that ... Infuse bone graft products are now available. Published this ... the two studies serve up two key findings: There ... Infuse and the traditional bone graft; and there is ...
(Date:6/18/2013)... Biomet hip lawsuit claims involving ... a multidistrict litigation in U.S. District Court, Northern District ... court records, the litigation’s most recent status conference was ... also convened a motions hearing and a tutorial on ... hip replacement litigation. The proceeding’s next Status Conference ...
Breaking Medicine News(10 mins):Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method 2Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3[0] Exposed Skin Care Review Released by ExposedSkinCareReview.org[0] Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method[0] Forceps Births Double, Obesity is Major Reason in Births Complications[0] Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments[0] Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation
(Date:6/18/2013)... , June 19, 2013 Paris Air ... as Geotest-Marvin Test Systems) , a leading provider ... aerospace industries, is demonstrating its solutions this week ... booth 3-C82. With growing challenges including increasingly complex ... demanding efficient, feature-rich, specialized aerospace test solutions that ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
(Date:6/18/2013)... the United Kingdom, the Energy Department,s National Renewable ... have recently published a paper describing a novel ... Limnoria quadripunctata , commonly known as the gribble. ... exhibit a relatively unique ability to produce their ... break down the biomass they eat. New biomass-degrading ...
Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |